https://cdn1.img.sputniknews.com/img/07e4/09/0a/1080419598_0:110:3321:1977_1200x675_80_0_0_6b1bd9926956c4e62688988ed1f71720.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/us/202010101080727372-us-signs-486mln-deal-with-astrazeneca-to-secure-100000-doses-of-antibody-treatment—hhs/ WASHINGTON (Sputnik) – The Trump administration has signed an agreement with biopharmaceutical giant AstraZeneca to develop and secure 100,000 doses of a cocktail antibody treatment for the novel coronavirus disease (COVID-19), Health and Human Services said in a press release. The release said the company’s antibody treatment, which is called AZD7442, is a cocktail of two monoclonal antibodies and […]
AstraZeneca
Competitors in the Covid-19 vaccine race are publishing clinical protocols in hopes of securing lucrative emergency approval, which Russia’s Sputnik V was previously attacked for seeking. This time, however, the media are quiet. The frontrunners in the US and western Europe’s quest to develop a coronavirus vaccine – Pfizer, AstraZeneca, and Moderna – have published their trial protocols in response to growing public unease over the […]
The Testing of the chimpanzee adenovirus-based vaccine had been repeatedly called into question for the “dangerous” lack of sufficient trials on chimp viruses as well as the unclear consequences of the new technology. The trials of AstraZeneca vaccine candidate remain on hold in the US. Days after AstraZeneca halted clinical trials of its COVID-19 vaccine over the case of unexplained neurological illness in one volunteer taking […]
by Fabio Giuseppe Carlo Carisio for VT Europe The devil makes the pots but not the lid. While the theory of the genetically modified organism built in the laboratory is becoming more and more concrete on the origin of the SARS-2 virus, here is the second hitch for one of the leading companies in the production of vaccines, the AstraZeneca of Anglo-Swedish ownership but actually controlled […]
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National […]
UPDATE ON SEPTEMBER, 11 The COVID-19 vaccine participant whose mysterious illness stopped the AstraZeneca coronavirus vaccine trials is reported to be an inflammatory syndrome known as transverse myelitis which may lead to paralysis. According to agreements with governments, the vaccine manufacturer cannot be legally held responsible for the side-effects of the coronavirus vaccine, for the ongonign pandemic emergency. The vaccine candidate, known as AZD1222 and developed […]
https://cdn1.img.sputniknews.com/img/07e4/08/1c/1080306907_0:306:3072:2034_1200x675_80_0_0_af8593d0dd04bfaec4f6a587b22cda3d.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/society/202009091080413621-astrazeneca-rejects-claim-covid-19-trial-was-halted-over-case-of-transverse-myelitis/ British-Swedish multinational pharmaceutical company AstraZeneca has rejected claims that its third round of trials for a COVID-19 vaccine was halted over a case of transverse myelitis, a neurological disorder characterized by inflammation of both sides of a section of the spinal cord. According to the company, its COVID-19 vaccine trial was paused in July after a volunteer was found […]
https://cdn1.img.sputniknews.com/img/105689/07/1056890761_0:114:2200:1352_1200x675_80_0_0_2932208db7d91200744ca8080e688a5d.jpg Sputnik International https://cdn2.img.sputniknews.com/i/logo.png Sputnik https://cdn2.img.sputniknews.com/i/logo.png https://sputniknews.com/uk/202008251080270125-uks-astrazeneca-begins-human-trial-of-covid-19-treatment-using-monoclonal-antibodies/ LONDON (Sputnik) – UK-based pharmaceutical company AstraZeneca announced on Tuesday that it had begun the human trial of a new treatment for COVID-19 using a combination of two monoclonal antibodies. “The first participants have been dosed in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) in development for the prevention and treatment of COVID-19,” […]
Brazil continues to struggle against the COVID-19 pandemic, which has severely struck the country, with more than 3.5 million confirmed cases and over 112,000 COVID-related deaths. Brazilian academic Fabio Sobral has shed light on the internal fight between the federal and local governments as well as the unfolding “vaccine race” in the country. The country’s President Jair Bolsonaro has been repeatedly subjected to criticism for his […]
Earlier this month France, Germany, Italy and the Netherlands joined forces to form the “Inclusive Vaccine Alliance”, in order to have a stronger negotiating position in the race for a coronavirus vaccine. The contract agreement with AstraZeneca is the alliance’s first result in securing a potential coronavirus vaccine for European countries. The Vaccine Alliance formed by France, Germany, Italy and the Netherlands has signed a contract […]